InvestorsHub Logo
Followers 292
Posts 76095
Boards Moderated 3
Alias Born 03/20/2013

Re: None

Tuesday, 05/23/2017 10:29:54 AM

Tuesday, May 23, 2017 10:29:54 AM

Post# of 21373
VERY IMPRESSIVE "ONCOLIX" CEO INTERVIEW (4/24/17)>>>


1. PRIVATE COMPANY "ONCOLIX" RECENTLY PURCHASED PUBLIC SHELL COMPANY "AEPP".

2. "ONCOLIX" HAS 8 PATENTS IN U.S. AND PATENTS IN OTHER COUNTRIES.

3. ALL "AEPP" DEBT WAS PAID OFF BY "ONCOLIX" AT PURCHASE.

4. "AEPP" HAS A LOW FLOAT: 33,311,633 a/o Apr 06, 2017 PER OTCMARKETS.COM: https://www.otcmarkets.com/stock/AEPP/profile

5. "ONCOLIX" HAS ORPHAN DRUG "PROLANTA" CURRENTLY IN FDA-APPROVED PHASE 1 TRIALS.

6. INVENTOR OF "PROLANTA" ALSO INVENTED "SOMAVERT" SOLD BY PFIZER. "SOMAVERT" YIELDED $232M IN REVS LAST YEAR.

7. APRIL 2017 "ONCOLIX" COMPANY PRESENTATION: https://nebula.wsimg.com/8b544fcbb6f5bf5fb52c1c7e5a69eb81?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

8. BRAND NEW "ONCOLIX" WEBSITE: https://www.oncolixbio.com/home.html

"The stock market is a device for transferring money from the impatient to the patient" — Warren Buffett

"The Big Money is not in the buying and the selling but in the waiting" — Charlie Munger

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.